J-M Manufacturing is pushing back against efforts by prominent asbestos law firm Simmons Hanly Conroy to end J-M's lawsuit accusing Simmons of a racket of "sham" asbestos lawsuits. The Simmons firm claims such racketeering claims aren't allowed against law firms over such litigation activities
CHICAGO (Legal Newsline) - Fraud drove asbestos lawsuits at the prominent plaintiffs firm Simmons Hanly Conroy, J-M Manufacturing Company is alleging in a new racketeering lawsuit.
State campaign finance disclosures reveal trial lawyers, their firms and political lobbying groups have donated more than $175,000 to Madigan's two campaign organizations since Sept. 30.
A federal judge has knocked down a $140 million verdict against pharmaceutical maker AbbVie, ordering a new trial over a man’s claims AbbVie’s Androgel testosterone replacement therapy drug caused him to suffer a heart attack.
North Chicago-based drugmaker AbbVie is resisting what it is calling a jury's “confused and inconsistent” $3.2 million verdict, after the company lost a second trial in Chicago federal court – one in which it was ordered to pay $147 million less than the first trial – over a man’s claims AbbVie allegedly failed to warn its product AndroGel could bring on a heart attack.
As the number of new asbestos lawsuits declined nationally, activity in Illinois’ three hotbeds for asbestos litigation showed few signs of ebbing in 2017, even though the distribution of filing activity has shifted slightly.
SAN FRANCISCO (Legal Newsline) - Plaintiff lawyers meeting in San Francisco last week for a conference on opioid litigation acknowledged that the hundreds of lawsuits they have filed in state and federal court will be difficult to resolve without an unprecedented national settlement whose mechanics are still difficult to predict.
Saying state law designates Chicago’s red light and speed camera enforcement programs as something different from ordinary traffic laws, a state appeals court has again handed a defeat to a class action attempting to overthrow the city’s automated traffic citation program, which annually adds millions of dollars in fines from ticketed motorists to the city’s coffers.
CLEVELAND (Legal Newsline) - The judge overseeing multidistrict litigation against opioid manufacturers and distributors has named the teams of lawyers who will try to negotiate a settlement of hundreds of federal lawsuits - a complex task given parallel investigations and litigation by state attorneys general and potentially conflicting goals of private attorneys and their government counterparts.
After split verdicts in two prior trials over alleged harmful side effects and alleged misleading marketing of its testosterone replacement drug led to questionable verdicts worth more than $140 million each, drugmaker Abbvie has scored a clean win in the latest jury review of a plaintiff’s claims over the promotion and health impacts of Androgel.
CLEVELAND (Legal Newsline) - There will be a lot of familiar faces in U.S. District Judge Dan Polster’s courtroom in Cleveland on Jan. 31, when lawyers gather for a hearing on multidistrict litigation against the nation’s opioid manufacturers and distributors.
SPRINGFIELD – Supreme Court Justices must decide whether suits that counties continue filing against opioid manufacturers belong with a judge from Cook County or a judge from Springfield.
Lawyers hired by Cook County to help press the county’s case against drug companies over the proliferation of opioid painkillers stand to pocket at least a quarter of Cook County’s cut of any settlement or dollar amount awarded by a court.
North Chicago-based drugmaker AbbVie has asked a federal judge to toss out a $140 million verdict against it for allegedly mismarketing its testosterone replacement therapy drug, Androgel. And in the view of a Chicago attorney whose practice focuses on Supreme Court and appellate cases, as well as class actions, there is "no chance" that judgment will be allowed to stand.
North Chicago-based drug company AbbVie is urging a federal judge to trash a verdict ordering it to cough up $140 million, because its testosterone therapy drug AndroGel contributed to a man's heart attack, contending it has no liability because AndroGel was approved by the FDA.
Drugmaker Abbvie has suffered another big loss in court, as a Chicago federal jury has ordered the North Chicago-based pharmaceutical company to pay out $140 million to another man who claimed he had suffered a heart attack as a result of taking Abbvie’s testosterone therapy drug, Androgel.
A machinist’s case against Union Pacific, claiming the railroad should be made to pay for allegedly exposing him to toxic fumes and products at work, allegedly causing his renal cancer, has been sent back to Cook County court, after a federal judge determined the Federal Employees Liability Act doesn't let it pull out of state court.
A Chicago federal judge has dismissed several. but not all of the claims against the maker of a testosterone boosting drug, advanced by several plaintiffs chosen as bellwethers in a class-action lawsuit brought by more than 2,000 plaintiffs from around the U.S. against multiple drug manufacturers, including Besins, AbbVie, Eli Lilly and GlaxoSmithKline.
A federal judge has denied a Belgian drug maker’s attempt to remove itself from a massive class-action lawsuit that claims testosterone replacement drugs caused harm to patients taking them for off-label conditions.
